Form 8-K - Current report:
SEC Accession No. 0001404644-26-000046
Filing Date
2026-06-29
Accepted
2026-06-29 08:00:50
Documents
52
Period of Report
2026-06-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20260629.htm   iXBRL 8-K 29265
2 EX-99.1 ngne_irsf2026datapressrele.htm EX-99.1 25886
3 EX-99.2 ngne_ngn-401june2026upda.htm EX-99.2 45493
7 image_0.jpg GRAPHIC 3474
8 ngne_ngn-401june2026upda001.jpg GRAPHIC 117174
9 ngne_ngn-401june2026upda002.jpg GRAPHIC 183831
10 ngne_ngn-401june2026upda003.jpg GRAPHIC 69092
11 ngne_ngn-401june2026upda004.jpg GRAPHIC 37333
12 ngne_ngn-401june2026upda005.jpg GRAPHIC 149423
13 ngne_ngn-401june2026upda006.jpg GRAPHIC 142694
14 ngne_ngn-401june2026upda007.jpg GRAPHIC 174199
15 ngne_ngn-401june2026upda008.jpg GRAPHIC 31420
16 ngne_ngn-401june2026upda009.jpg GRAPHIC 125021
17 ngne_ngn-401june2026upda010.jpg GRAPHIC 146987
18 ngne_ngn-401june2026upda011.jpg GRAPHIC 89533
19 ngne_ngn-401june2026upda012.jpg GRAPHIC 100570
20 ngne_ngn-401june2026upda013.jpg GRAPHIC 70088
21 ngne_ngn-401june2026upda014.jpg GRAPHIC 149096
22 ngne_ngn-401june2026upda015.jpg GRAPHIC 53129
23 ngne_ngn-401june2026upda016.jpg GRAPHIC 100359
24 ngne_ngn-401june2026upda017.jpg GRAPHIC 98039
25 ngne_ngn-401june2026upda018.jpg GRAPHIC 136056
26 ngne_ngn-401june2026upda019.jpg GRAPHIC 98334
27 ngne_ngn-401june2026upda020.jpg GRAPHIC 103526
28 ngne_ngn-401june2026upda021.jpg GRAPHIC 99709
29 ngne_ngn-401june2026upda022.jpg GRAPHIC 149151
30 ngne_ngn-401june2026upda023.jpg GRAPHIC 44259
31 ngne_ngn-401june2026upda024.jpg GRAPHIC 36344
32 ngne_ngn-401june2026upda025.jpg GRAPHIC 97422
33 ngne_ngn-401june2026upda026.jpg GRAPHIC 113233
34 ngne_ngn-401june2026upda027.jpg GRAPHIC 134663
35 ngne_ngn-401june2026upda028.jpg GRAPHIC 105972
36 ngne_ngn-401june2026upda029.jpg GRAPHIC 124951
37 ngne_ngn-401june2026upda030.jpg GRAPHIC 99403
38 ngne_ngn-401june2026upda031.jpg GRAPHIC 37957
39 ngne_ngn-401june2026upda032.jpg GRAPHIC 138084
40 ngne_ngn-401june2026upda033.jpg GRAPHIC 126449
41 ngne_ngn-401june2026upda034.jpg GRAPHIC 79924
42 ngne_ngn-401june2026upda035.jpg GRAPHIC 49136
43 ngne_ngn-401june2026upda036.jpg GRAPHIC 127985
44 ngne_ngn-401june2026upda037.jpg GRAPHIC 105837
45 ngne_ngn-401june2026upda038.jpg GRAPHIC 75152
  Complete submission text file 0001404644-26-000046.txt   5654034

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20260629.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20260629_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20260629_pre.xml EX-101.PRE 13050
55 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20260629_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 261131419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)